Covered recipient · General Payments record
ADAM C RHODES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,352.28
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $738.99 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $170.20 | 2 |
| PFIZER INC. | $147.17 | 8 |
| SANOFI-AVENTIS U.S. LLC | $107.32 | 5 |
| Lilly USA, LLC | $95.11 | 4 |
| GlaxoSmithKline, LLC. | $71.78 | 3 |
| Astellas Pharma US Inc | $54.47 | 2 |
| Novo Nordisk AS | $41.12 | 2 |
| Acerta Pharma LLC | $18.39 | 1 |
| Merck Sharp & Dohme Corporation | $17.81 | 1 |
| Phadia US Inc. | $15.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $142.73 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111687522 | CMS |
| Amgen Inc. | $27.47 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363857 | CMS |
| Astellas Pharma US Inc | $31.73 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139390084 | CMS |
| Astellas Pharma US Inc | $22.74 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139434834 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.39 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104631394 | CMS |
| GlaxoSmithKline, LLC. | $32.80 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115755920 | CMS |
| GlaxoSmithKline, LLC. | $18.95 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116244270 | CMS |
| GlaxoSmithKline, LLC. | $20.03 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116648163 | CMS |
| Lilly USA, LLC | $28.67 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136005495 | CMS |
| Lilly USA, LLC | $27.81 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136002699 | CMS |
| Lilly USA, LLC | $15.97 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136002701 | CMS |
| Lilly USA, LLC | $22.66 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136005497 | CMS |
| Merck Sharp & Dohme LLC | $17.81 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141630386 | CMS |
| Novo Nordisk Inc | $20.24 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096919740 | CMS |
| Novo Nordisk Inc | $20.88 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096901509 | CMS |
| PFIZER INC. | $21.36 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130992004 | CMS |
| PFIZER INC. | $7.52 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130885466 | CMS |
| PFIZER INC. | $26.13 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131229417 | CMS |
| PFIZER INC. | $21.72 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131317553 | CMS |
| PFIZER INC. | $4.99 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132069973 | CMS |
| PFIZER INC. | $13.47 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131787212 | CMS |
| PFIZER INC. | $25.36 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131871073 | CMS |
| PFIZER INC. | $26.62 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132107804 | CMS |
| Phadia US Inc. | $15.62 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067574804 | CMS |
| SANOFI-AVENTIS U.S. LLC | $25.02 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139642538 | CMS |
| SANOFI-AVENTIS U.S. LLC | $25.69 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139642546 | CMS |
| SANOFI-AVENTIS U.S. LLC | $22.94 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139642554 | CMS |
| SANOFI-AVENTIS U.S. LLC | $18.38 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139642562 | CMS |
| SANOFI-AVENTIS U.S. LLC | $15.29 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139642588 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.